UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PloS one, 2014, Vol.9 (6), p.e100392

2014

Volltextzugriff (PDF)

Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies

Cell reports (Cambridge), 2024-10, Vol.43 (10), p.114811, Article 114811

2024

Volltextzugriff (PDF)

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus

Frontiers in immunology, 2024-06, Vol.15, p.1376395

2024

Volltextzugriff (PDF)

Immunopathology of RSV: An Updated Review

Viruses, 2021-12, Vol.13 (12), p.2478

2021

Volltextzugriff (PDF)

Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus

Frontiers in immunology, 2018-03, Vol.9, p.323-323

2018

Volltextzugriff (PDF)

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

PloS one, 2015-09, Vol.10 (9), p.e0138018-e0138018

2015

Volltextzugriff (PDF)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

PloS one, 2017-04, Vol.12 (4), p.e0175792-e0175792

2017

Volltextzugriff (PDF)

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

Frontiers in immunology, 2024-04, Vol.15, p.1377374-1377374

2024

Volltextzugriff (PDF)

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

PloS one, 2015-03, Vol.10 (3), p.e0119509-e0119509

2015

Volltextzugriff (PDF)

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

PloS one, 2013, Vol.8 (10), p.e77104

2013

Volltextzugriff (PDF)

Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves

Scientific reports, 2019-10, Vol.9 (1), p.15157-14, Article 15157

2019

Volltextzugriff (PDF)

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Frontiers in immunology, 2024-05, Vol.15, p.1374818-1374818

2024

Volltextzugriff (PDF)

Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins

Frontiers in immunology, 2024-07, Vol.15, p.1406929

2024

Volltextzugriff (PDF)

Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine

PloS one, 2018-06, Vol.13 (6), p.e0199452-e0199452

2018

Volltextzugriff (PDF)

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus

Scientific reports, 2021-11, Vol.11 (1), p.21358-21358, Article 21358

2021

Volltextzugriff (PDF)

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

Nature medicine, 2006-08, Vol.12 (8), p.905-907

2006

Volltextzugriff (PDF)

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

PLoS medicine, 2013-11, Vol.10 (11), p.e1001549-e1001549

2013

Volltextzugriff (PDF)

Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F

PLoS pathogens, 2020-11, Vol.16 (11), p.e1008943-e1008943

2020

Volltextzugriff (PDF)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model

Scientific reports, 2017-02, Vol.7 (1), p.42428-42428, Article 42428

2017

Volltextzugriff (PDF)

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice

PloS one, 2012-05, Vol.7 (5), p.e36812-e36812

2012

Volltextzugriff (PDF)

Respiratory Syncytial Virus Vaccine Design Using Structure-Based Machine-Learning Models

Viruses, 2024-05, Vol.16 (6), p.821

2024

Volltextzugriff (PDF)

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?

Current opinion in infectious diseases, 2015-06, Vol.28 (3), p.221-224

Munoz, Flor M

2015

Volltextzugriff (PDF)

From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older Adults

Viruses, 2024-04, Vol.16 (4), p.531

2024

Volltextzugriff (PDF)

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease

PloS one, 2011-07, Vol.6 (7), p.e21823

2011

Volltextzugriff (PDF)

In vitro model for the assessment of human immune responses to subunit RSV vaccines

PloS one, 2020, Vol.15 (3), p.e0229660

2020

Volltextzugriff (PDF)

1 – 25 von 1.631

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.604)
Mit Volltextzugriff
(1.090)

Publikationsform

Artikel
(1.631)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.545)
Life Sciences & Biomedicine
(1.321)
Respiratory Syncytial Virus
(1.157)
Immunology
(1.135)
Humans
(1.120)
Infectious Diseases
(633)
Female
(607)
Pediatrics
(570)
Infant
(559)
Animals
(553)
Male
(473)
Biological And Medical Sciences
(424)
Viruses
(421)
Infections
(412)
Respiratory Syncytial Virus Infections - Immunology
(405)
Medical Sciences
(361)
Child, Preschool
(327)
Infant, Newborn
(316)
Mice
(290)
Vaccines
(284)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus

Immunopathology of RSV: An Updated Review

Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Systematic computer-aided disulfide design as a general strategy to stabilize prefusion class I fusion proteins

Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

Convergent structural features of respiratory syncytial virus neutralizing antibodies and plasticity of the site V epitope on prefusion F

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice

Respiratory Syncytial Virus Vaccine Design Using Structure-Based Machine-Learning Models

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?

From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older Adults

A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease

In vitro model for the assessment of human immune responses to subunit RSV vaccines

Aktive Filter

Suchergebnisse filtern